top of page
Triomics headquarters in San Francisco, California
Of course, a sound idea still requires solid execution. So why are we confident in our approach?

OUR RESULTS

We believe in transparently sharing our results and methods. You can view our published and submitted manuscripts on our insights page.

OUR PARTNERS

We’d point to our leadership in creating a consortium of over 20 NCI-designated cancer centers, along with Ci4CC. The group, named the Collaboration for Oncology focused LLM Training (COLT), recognizes that generative AI is a nascent technology and oncology is a zero-fail space. We therefore partner together to share best practices, and determine performance benchmarks and safety standards.
Finally, we recognize that generative AI is a new technology and any model, no matter how well developed, will have limitations. Accordingly, we strive for:

01

True Collaboration

Success in healthcare AI often requires collaborative efforts. We foster teamwork not only within our company but also with our partner providers, integrating their insights to continually refine and enhance our AI and software. Together, we create solutions that are more than the sum of their parts.

02

Constant Support

We provide continuous support and tailored learning opportunities for our end users to ensure they can best utilize our solutions. Our goal is to empower healthcare professionals with advanced tools needed for optimal patient care and innovative research.

03

Responsible Innovation

In the critical field of oncology, we hold ourselves to the highest standards of ethical innovation. Our work is provider- and patient-centric, ensuring that our advancements in healthcare AI are developed responsibly, with a commitment to doing no harm and prioritizing safety above all.

04

Meaningful Impact

Our focus is on creating a significant positive impact in the lives of cancer patients and the healthcare teams who care for them. We measure success by the real-world utility and effectiveness of our solutions, aiming to transform oncology care through technology.

Swipe right to scroll.

Swipe right to scroll.

OUR TEAM

Sarim Khan

Co-Founder and CEO

Hrituraj Singh

Co-Founder and CTO

Regina Schwind

Clinical Data

Sebastien Rhodes

Strategy and Operations

Daniel Novinson

Medical Director

Aniket Jaiswal

GTM & Market Intelligence

Lora Lafon 

Partnerships

Rohitdev Kulshrestha

Engineering

Paul Deleanu

Security and Compliance

Surbhi Chamoli

Design

Mauro Nievas

AI/ML

Yashwardhan Singh

Product Management

Swipe right to scroll.

Swipe right to scroll.

OUR INVESTORS

Our investors include Lightspeed, Nexus, Y Combinator, and General Catalyst, firms with a track record of expertise in AI and digital health.
Nexus Venture Partners
Nexus Venture Partners
Lightspeed Venture Partners
Y Combinator
General Catalyst Partners
Image by National Cancer Institute

Next Page

CONTACT US

partnerships@triomics.com

contact@triomics.com

888-ONCO-LLM

(888-662-6556)

601 Montgomery St, Suite 1100
San Francisco, CA 94111

Copyright 2024

FierceHealthcare

PRESS MENTIONS

Forbes
TechCrunch
VentureBeat

Article Link

FierceHealthcare

Article Link

Forbes

Article Link

TechCrunch

Article Link

PRESS MENTIONS

We're honored to have been featured in over 40 outlets, including:
Forbes

Article Link

VentureBeat

Article Link

FierceHealthcare

Article Link

TechCrunch

Article Link

PRESS MENTIONS

We're honored to have received coverage in several media outlets.
Forbes
FierceHealthcare
TechCrunch
VentureBeat
Nexus Venture Partners
(Click on each logo below to read the corresponding article.)
bottom of page